首页> 外国专利> STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro

STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro

机译:肠病毒柯萨奇B6菌株体外选择性感染和裂解人类肿瘤细胞

摘要

FIELD: biotechnologies.;SUBSTANCE: described strain is produced by performance of a series of adaptation passages of a parent strain of the virus ZhEV-15 Coxsackie B6 on the culture of cells HEK293 highly sensitive to this virus and the neoplastic cell line C33A (HPV-negative carcinoma of human uterine neck), with production of a new strain ZhEV-15L of the virus Coxsackie B6. The strain selectively infects and lyses tumorous human cells and has a fragment of a genome sequence represented in the dwg. 2, being its marker criterion. The strain is deposited in the State Collection of the Federal Service for Oversight of Consumer Protection and Welfare of agents of viral infections and rickettsial diseases of the Federal Budget Institution of Science State Science Centre of Virusology and Biotechnology "Vector" under the registration number V-576.;EFFECT: invention provides for the possibility of promising development of a viral oncolytic preparation on its basis for therapy of malignant human tumours and definition of a full nucleotide sequence of its genome.;3 dwg, 4 tbl, 2 ex
机译:领域:生物技术;物质:所描述的菌株是通过病毒ZhEV-15柯萨奇B6亲本菌株在对该病毒高度敏感的HEK293细胞和赘生性细胞系C33A(HPV)的培养中进行一系列适应传代而产生的-人子宫颈部阴性癌),并产生了一种新的Coxsackie B6病毒ZhEV-15 L 株。该菌株选择性地感染和裂解肿瘤性人类细胞,并具有以dwg表示的基因组序列的片段。 2,为其标记标准。该病毒株已存放在联邦预算科学研究院病毒学和生物技术中心“病毒媒介”的联邦预算机构病毒感染和立克次氏病的消费者保护和福利监督联邦服务局的国家收集库中,注册号为V- 576 .;效果:本发明提供了有前景的病毒溶瘤制剂的开发可能性,其基于其治疗恶性人肿瘤和确定其基因组的完整核苷酸序列。3 dwg,4 tbl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号